ZAMO', Alberto
 Distribuzione geografica
Continente #
EU - Europa 7.088
NA - Nord America 6.919
AS - Asia 4.423
SA - Sud America 530
AF - Africa 58
OC - Oceania 14
Continente sconosciuto - Info sul continente non disponibili 9
AN - Antartide 1
Totale 19.042
Nazione #
US - Stati Uniti d'America 6.823
RU - Federazione Russa 2.554
SG - Singapore 1.786
GB - Regno Unito 1.650
CN - Cina 1.602
IT - Italia 521
SE - Svezia 454
DE - Germania 438
FR - Francia 435
BR - Brasile 419
FI - Finlandia 373
HK - Hong Kong 350
IE - Irlanda 281
VN - Vietnam 265
UA - Ucraina 135
KR - Corea 114
CA - Canada 64
BE - Belgio 61
IN - India 53
TR - Turchia 52
AR - Argentina 46
JP - Giappone 46
NL - Olanda 41
ES - Italia 32
ID - Indonesia 32
PL - Polonia 30
MX - Messico 23
ZA - Sudafrica 22
IR - Iran 20
BD - Bangladesh 19
EC - Ecuador 17
LT - Lituania 16
AT - Austria 15
AU - Australia 13
CL - Cile 12
IQ - Iraq 12
VE - Venezuela 12
CO - Colombia 11
IL - Israele 11
CH - Svizzera 8
NP - Nepal 8
UZ - Uzbekistan 8
JO - Giordania 7
KE - Kenya 7
PK - Pakistan 7
RO - Romania 7
AZ - Azerbaigian 6
DZ - Algeria 6
CZ - Repubblica Ceca 5
A2 - ???statistics.table.value.countryCode.A2??? 4
EG - Egitto 4
MA - Marocco 4
PE - Perù 4
PY - Paraguay 4
AL - Albania 3
BG - Bulgaria 3
BO - Bolivia 3
CI - Costa d'Avorio 3
EE - Estonia 3
EU - Europa 3
HU - Ungheria 3
KZ - Kazakistan 3
LU - Lussemburgo 3
LV - Lettonia 3
MY - Malesia 3
TN - Tunisia 3
BY - Bielorussia 2
GT - Guatemala 2
KG - Kirghizistan 2
LA - Repubblica Popolare Democratica del Laos 2
LB - Libano 2
NO - Norvegia 2
PA - Panama 2
PS - Palestinian Territory 2
PT - Portogallo 2
RS - Serbia 2
SA - Arabia Saudita 2
SK - Slovacchia (Repubblica Slovacca) 2
TH - Thailandia 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
AE - Emirati Arabi Uniti 1
AF - Afghanistan, Repubblica islamica di 1
AQ - Antartide 1
BN - Brunei Darussalam 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GE - Georgia 1
GN - Guinea 1
GR - Grecia 1
HR - Croazia 1
JM - Giamaica 1
KH - Cambogia 1
LY - Libia 1
MG - Madagascar 1
MK - Macedonia 1
MU - Mauritius 1
NG - Nigeria 1
Totale 19.034
Città #
Southend 1.480
Jacksonville 990
Singapore 902
Moscow 867
Chandler 824
Dallas 717
Woodbridge 524
Ann Arbor 466
Ashburn 448
Hong Kong 346
Beijing 293
Dublin 281
Houston 269
Wilmington 157
Lawrence 143
Princeton 143
New York 132
Los Angeles 122
Jinan 121
The Dalles 121
Nanjing 119
Verona 97
Shenyang 91
Munich 90
Ho Chi Minh City 89
Hebei 70
Helsinki 69
Sindelfingen 67
Tianjin 67
Buffalo 66
Brussels 60
Boardman 56
Ningbo 56
Hanoi 54
Nanchang 54
Columbus 53
Turku 50
Haikou 41
Zhengzhou 40
Tokyo 39
Milan 37
Changsha 36
Taizhou 34
Guangzhou 33
Hangzhou 33
Jiaxing 33
Redondo Beach 33
Dearborn 32
Chicago 29
São Paulo 27
Taiyuan 27
Bologna 26
Santa Clara 25
Fairfield 24
San Francisco 24
Warsaw 24
Norwalk 23
Montreal 22
Seoul 22
Stockholm 22
Lancaster 21
Redmond 21
Groningen 19
Denver 18
Falls Church 18
Rome 18
Atlanta 17
Falkenstein 17
Frankfurt am Main 17
Johannesburg 17
Brooklyn 16
Fuzhou 15
Jakarta 15
Phoenix 15
Rio de Janeiro 15
Chennai 14
London 14
Toronto 14
Haiphong 13
Redwood City 13
Seattle 13
Amsterdam 12
Brasília 12
Madrid 12
Orem 12
Council Bluffs 11
Dongguan 11
Düsseldorf 11
Kent 11
Leawood 11
San Jose 11
Washington 11
Belo Horizonte 10
Boston 10
Curitiba 10
Dong Ket 10
Lanzhou 10
Wuhan 10
Zanjan 10
Clearwater 9
Totale 11.784
Nome #
Epidemiology of mastocytosis in adults based on a multidisciplinary diagnostic approach. 299
Leucemia linfatica cronica/linfoma linfocitico (LLC): l'espressione di ZAP-70, analizzata alla diagnosi su biopsia ossea, è un importante fattore prognostico 295
Endothelin B Receptor (Etbr) expression by human malignant plasma cells: preliminary evidence for a role of the endothelin axis in multiple myeloma. 233
B-cell chronic lymphocytic leukemia cells espress functional death receptor 3 following stimulation of the B cell receptor 231
Chromium-induced diffuse dermatitis with lymph node involvement resulting from Langerhans cell histiocytosis after metal-on-metal hip resurfacing 225
Detection of allele-specific gene expression on next generation sequencing data 212
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 212
Expression and function of the TL1A/DR3 axis in chronic lymphocytic leukemia 211
[Primary large B cell non-Hodgkin's lymphoma of the mediastinum] 209
slan+ monocytes and macrophages mediate CD20-dependent B cell lymphoma elimination via ADCC and ADCP 203
Analysis of colorectal cancers for human cytomegalovirus presence 201
EXPRESSION AND FUNCTIONAL ACTIVITY OF DEATH RECEPTOR 3 IN B-CELL CHRONIC LYMPHOCYTIC LEUKEMIA 201
Endothelin-1 receptor blockade as new possible therapeutic approach in multiple myeloma. 201
Clonal mast cell disorders limited to bone marrow: not a negligible disease. 200
Absence of TCL1A expression is a useful diagnostic feature in splenic marginal zone lymphoma. 198
Cellular senescence markers p16INK4 and p21CIP1/WAF are predictors of Hodgkin's lymphoma outcome 197
Application of a commercial software to the analysis of infrared structural images on lymph node tissues: a preliminary study 196
Espressione di TP73L nei linfomi B a grandi cellule primitivi del mediastino: un utile marcatore diagnostico 195
Espressione di marcatori di migrazione e invasività nei foci fibroblastici nella fibrosi polmonare idiopatica 192
Prevalence, pathogenesis, and treatment options for mastocytosis-related osteoporosis 192
Diagnostic utility of S100A1 expression in renal cell neoplasms: an immunohistochemical and quantitative RT-PCR study 190
CD10 is expressed in a subset of chromophobe renal cell carcinomas 188
ALK-positive anaplastic large cell lymphoma with PAX-5 expression: report of a case 188
Aberrant Wnt/beta-catenin pathway activation in idiopathic pulmonary fibrosis 186
Rapid reconstitution of functionally active 6-sulfoLacNAc(+) dendritic cells (slanDCs) of donor origin following allogeneic haematopoietic stem cell transplant 185
Autoimmune complications are frequent in splenic and nodal marginal zone lymphomas 182
A Rare Disorder in an Orphan Disease: Kikuchi Fujimoto Disease in a Young-Adult Patient with Sickle Cell Anemia 179
Value of flow cytometry in the diagnosis of indolent systemic mastocytosis. 178
Hairy cell leukemia in kidney transplantation: lesson from a rare disorder. 176
In reply to Schäfer et al: new evidence on the role of endothelin-1 axis as a potential therapeutic target in multiple myeloma 174
Haploidentical hematopoietic stem cell transplantation in a myelofibrosis patient with primary graft failure 171
The TNF-Family Cytokine TL1A Inhibits Proliferation of Human Activated B Cells 169
Mantle cell lymphoma cell lines show no evident immunoglobulin heavy chain stereotypy but frequent light chain stereotypy 168
Improvement of maternal and fetal outcomes in women with sickle cell disease treated with early prophylactic erythrocytapheresis 164
Application of Microfluidic Technology to the BIOMED-2 Protocol for Detection of B-Cell Clonality 162
The impact of sensitive KIT D816V detection on recognition of Indolent Systemic Mastocytosis 162
A 6-GENE EXPRESSION SIGNATURE IN MANTLE CELL LYMPHOMA: RESULTS FROM THE FONDAZIONE ITALIANA LINFOMI (FIL)-MCL-0208 TRIAL 161
Microfluidic Deletion/Insertion Analysis for Rapid Screening of KIT and PDGFRA Mutations in CD117-Positive Gastrointestinal Stromal Tumors: Diagnostic Applications and Report of a New KIT Mutation. 160
Establishment of the MAVER -1 cell line, a model for leukemic and aggressive mantle cell lymphoma. 159
Utilizzo di un apparato microfluidico per il rilevamento del riarrangiamento clonale dei geni delleimmunoglobuline secondo il protocollo BIOMED-2 157
FPA micro spectral imaging of non-Hodgkin lymphomas 157
Evaluation of S-phase fraction as a prognostic marker in mantle cell lymphoma 157
Use of a Chip-based microfluidic apparatus in the analytic step of the Biomed-2 protocol for the detection of B-cell clonality 155
In Vitro and In Vivo Model of EBV-Positive Non-Hodgkin Plasmablastic Lymphoma with Focal Plasmacytic Differentiation 155
MYC-related microRNAs signatures in non-Hodgkin B-cell lymphomas and their relationships with core cellular pathways 153
EXPRESSION AND FUNCTIONAL ACTIVITY OF THE TNFR-SUPERFAMILY MEMBER DEATH RECEPTOR 3 IN CHRONIC LYMPHOCYTIC LEUKEMIA B CELLS ACTIVATED BY THE BCR 152
Identification of the core phosphoproteome of mantle cell lymphoma cell lines 151
Phospho-proteomic analysis of mantle cell lymphoma cells suggests a pro-survival role of B-cell receptor signaling. 150
The role of disease causing genes in sporadic pancreatic endocrine tumors: MEN1 and VHL. 149
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol: a proteomic analysis. 149
PEROXIREDOXIN-2: A NOVEL REGULATOR OF IRON HOMEOSTASIS IN INEFFECTIVE ERYTHROPOIESIS 149
ALK-mediated activation of STAT3 elicits growth and anti-apoptotic signals. 148
Constitutive expression of DeltaN-p63alpha isoform in human thymus and thymic epithelial tumours 146
Anaplastic lymphoma kinase (ALK) activates Stat3 and protects hematopoietic cells from cell death 146
An unusual case of sarcoidosis in an adult patient with sickle cell disease: Management with methotrexate and low dose of steroid 146
The TNF-Family Cytokine TL1A/Death Receptor 3 System Reduces Metabolic Activity in Chronic Lymphocytic Leukemia B Cells 146
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathway as a potential therapeutic target. 144
Signal transduction pathways of mantle cell lymphoma: a phosphoproteome-based study. 144
Phospho-tyrosine profiling of mantle cell lymphoma cells suggests the BCR signalling pathwayn as a potential therapeutic target 143
Activated KIT hyperexpression in thymic carcinoma: a potential target for therapeutic intervention. 142
GREY ZONES OF HODGKIN LYMPHOMA: REPORT OF A CASE WITH FEATURES INTERMEDIATE BETWEEN PRIMARY MEDIASTINAL B-CELL LYMPHOMA, CLASSICAL HODGKIN LYMPHOMA AND NODULAR LYMPHOCYTE-PREDOMINANT HODGKIN LYMPHOMA 141
Short-term, intensive chemotherapy regimen is equally effective in Burkitt lymphoma (BL) and in the novel WHO 2008 entity “B-cell lymphoma intermediate between DLBCL and BL". 140
Tissue proteomics of splenic marginal zone lymphoma 137
Application of a commercial software to the analysis of infrared spectral images on lymph node tissues: a preliminary study. 136
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 135
ATM Deficiency Sensitizes Mantle Cell Lymphoma Cells to Poly(ADP-Ribose) Polymerase-1 Inhibitors 134
Group 3 innate lymphoid cells regulate neutrophil migration and function in human decidua 134
Utilizzo dell'analisi microfluidica per il rilevamento di mutazioni dei geni KIT e PDGFRA nei tumori dello stroma gastroenterico. 133
PHOSPHOSCAN ANALYSIS OF MANTLE CELL LYMPHOMA CELL LINES 132
CD30 expression by bone marrow mast cells from different diagnostic variants of systemic mastocytosis 132
THE TNF-FAMILY CYTOKINE TL1A/DEATH RECEPTOR 3 FUNCTIONAL AXIS MODULATES B- CELL CHRONIC LYMPHOCYTIC LEUKEMIA PROLIFERATION 131
Anaplastic lymphoma kinase in human cancer 129
Anaplastic large-cell lymphoma 129
Classical Hodgkin lymphoma cells may promote an IL-17-enriched microenvironment 129
Quantitative study of ductal breast cancer progression: signatures of nuclei in proliferating breast lesions and in situ cancer. 127
Oncogene-induced senescence distinguishes indolent from aggressive forms of pulmonary and non-pulmonary Langerhans cell histiocytosis 126
CD16 expression in T-cell lymphomas: analysis on paraffin embedded tissues using the 2H7 antibody. 123
Metodi e tecniche dell'anatomia patologica 123
ZAP-70 expression is associated with increased risk of autoimmune cytopenias in CLL patients 123
Modified HyperCVAD and rituximab for the treatment of B-cell lymphoma, unclassifiable, with features intermediate between diffuse large B-cell lymphoma and Burkitt lymphoma. 123
The mantle cell lymphoma website: a free web-based resource for mantle cell lymphoma researchers 122
VR09 Cell Line: An EBV-Positive Lymphoblastoid Cell Line with In Vivo Characteristics of Diffuse Large B Cell Lymphoma of Activated B-Cell Type 122
Resveratrol activity on MCL cell line jeko-1: a proteomic approach 120
Systemic mastocytosis associated with myelodysplastic/myeloproliferative neoplasms with ring sideroblasts and thrombocytosis: Report of three cases 119
Precise sequance analysis of rearranged immunoglobulin genes in mantle cell lymphoma cell lines 116
Phosphoproteome profiling of mantle cell lymphoma cell lines 115
MicroRNA signatures and Foxp3+ cell count correlate with relapse occurrence in follicular lymphoma 114
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 113
HHV-8 and EBV are not commonly found in idiopathic pulmonary fibrosis 112
Identification of a three-gene model as a powerful diagnostic tool for the recognition of ALK negative ALCL 110
Expression of TP73L is a helpful diagnostic marker of primary mediastinal large B-cell lymphomas 108
Induction of apoptosis in Jeko-1 mantle cell lymphoma cell line by resveratrol : a proteomic analysis 105
Models for quantitative individual grading and prognosis in breast malignancies 104
Genome-Wide Promoter Methylation Profiling Of Splenic Marginal Zone Lymphoma (SMZL) Identifies Two Subgroups Of Patients With Distinct Genetic and Biologic Features and Different Outcomes 104
TCL1A expression in marginal zone lymphoma: a clinico-pathological evaluation in paired spleen and bone marrow samples 103
The exomic landscape of t(14;18)-negative diffuse follicular lymphoma with 1p36 deletion 103
Quantitative evaluation of differential expression of p63 isoforms in primary mediastinal B-cell lymphomas by real-time PCR 100
Patologia della cellula 98
Stat3 and Ras activation are required for the cellular transformation mediated by NPM-ALK 97
Stat3 is required for ALK-mediated lymphomagenesis and provides a possible therapeutic target. 97
Totale 15.543
Categoria #
all - tutte 61.532
article - articoli 34.163
book - libri 0
conference - conferenze 26.351
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.018
Totale 123.064


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021610 0 0 0 0 0 140 17 95 89 20 202 47
2021/20221.198 99 398 5 96 44 28 13 76 47 41 105 246
2022/20232.380 174 241 248 438 223 523 16 141 275 20 53 28
2023/20241.095 59 102 78 145 132 178 42 74 15 48 146 76
2024/20252.799 135 230 87 474 122 78 132 89 468 172 251 561
2025/20265.562 590 489 672 1.329 2.024 458 0 0 0 0 0 0
Totale 19.166